Sponsor or institution
Clinical trials and research at Celdara Medical, LLC
As of November 12, 2026, Find a Trial lists 12 NIH-funded research projects at this institution, with $8.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12NIH research projects
NIH-funded research (12)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Engineered regulatory T cells as a therapy for Gaucher disease
A new cell-based therapy using engineered regulatory T cells to help people with Gaucher disease, a type of lysosomal storage disorder.
-
Precision CAR-NK therapy to selectively remove autoreactive B cells in autoimmune diseases
A new, targeted cell therapy aims to remove disease-causing B cells in lupus while preserving the rest of the immune system.
-
Immunotherapy for Osteomyelitis: a new IL-2 based treatment
A new treatment approach is being explored to help bone infections like osteomyelitis by using a specialized immune-boosting agent to enhance the body’s own defense against bacteria.
-
Allogeneic Cell Therapy for Difficult-to-Treat IBD
A new allogeneic cell therapy is being developed to help adults with stubborn inflammatory bowel disease who have not responded well to other treatments.
-
CM-HZ01: a new high-boost IL-2 therapy for advanced melanoma
A new IL-2 based treatment called CM-HZ01 is being developed to help people with metastatic melanoma by steering the immune system toward stronger anti-tumor activity with potentially fewer side effects.
-
Engineered regulatory immune cells to protect nerves in ALS
Engineered regulatory immune cells (CAR Tregs) that seek out misfolded SOD1 and calm inflammation around motor neurons in people with ALS.
-
Using engineered immune cells to treat ALS
This study is exploring a new way to help people with ALS by using specially designed immune cells to target harmful proteins in the body, with the hope of reducing inflammation and slowing down the disease.
-
Developing a new treatment for metastatic melanoma using a specialized form of interleukin-2.
This study is testing a new treatment called CM-HZ01 that helps boost your immune system to fight metastatic melanoma by specifically activating certain immune cells, aiming to make the existing IL-2 therapy work better with fewer side effects for patients who don’t have many options left.
-
New treatment to protect brain cells during a stroke
This study is testing a new treatment that aims to protect brain cells during a stroke, which could help improve recovery and reduce long-term disability for stroke patients.
-
Using anti-hIAPP to protect pancreatic function in Type 2 Diabetes
This study is looking at how a treatment called anti-hIAPP can help protect the pancreas and improve insulin production for people with Type 2 Diabetes by targeting harmful proteins that can damage insulin-producing cells.
-
Creating a new antibody treatment for high-risk influenza outbreaks
This study is testing a new treatment called CM-PW3, which is a special antibody that could help protect people at high risk from serious flu strains, like H5N1 and H7N9, and it aims to find the best way to deliver this protection and see how long it lasts.
-
Developing a new treatment for ovarian and kidney cancers using CAR T-cell therapy.
This study is testing a new treatment called CM-CX1 that uses your own immune cells to help fight ovarian clear cell and renal cell cancers, aiming to make the treatment more effective than what’s currently available.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.